Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Pan, PA

Guisheng Pan, Philadelphia, PA US

Patent application numberDescriptionPublished
20120070478COLOR CHANGING CONSUMER PRODUCTS - The invention relates to personal care products containing multilayer films with decorative layers and may impart a noticeable color change. The invention is applicable in products including type toothpaste, soaps, and other products until diluted with water (or saliva).03-22-2012
20140161735COLOR CHANGING CONSUMER PRODUCTS - The invention relates to personal care products containing multilayer films with decorative layers and may impart a noticeable color change. The invention is applicable in products including type toothpaste, soaps, and other products until diluted with water (or saliva).06-12-2014
20140322140ORAL CARE COMPOSITIONS COMPRISING COLOR CHANGING FILMS - Described herein are powder coated films comprising a polymer matrix designed for use in a children's toothpaste, compositions comprising the films; and methods of making and using the same.10-30-2014
20150297480Dentifrice Compositions Changing of Color When Tooth Brushing - Described herein are powder coated films comprising a polymer matrix designed for use in a toothpaste to indicate a color change during brushing, dentifrice compositions comprising the films, and methods of making and using the same.10-22-2015

Patent applications by Guisheng Pan, Philadelphia, PA US

Jiyan Pan, Pittsburgh, PA US

Patent application numberDescriptionPublished
20130044942EVENT DETECTION THROUGH PATTERN DISCOVERY - Events are classified through string pattern recognition. Text labels are assigned to image primitives in a time-ordered set of training images and to related time-ordered transactions in an associated training transaction log in a combined time-ordered training string of text labels as a function of image types. Transactions are labeled in a training transaction log with a transaction label, a training primitive image of a start of a transaction with a start image text label, a training primitive of an entry of a transaction into the log with an entry image text label, and a training primitive of a conclusion of a transaction with an ending image text label. Positive subset string patterns are discovered representing true events from the combined time-ordered training string of text labels, and negative subset string patterns defined by removing single transaction primitive labels from the positive subset string patterns.02-21-2013
20130051613MODELING OF TEMPORARILY STATIC OBJECTS IN SURVEILLANCE VIDEO DATA - A foreground object blob having a bounding box detected in frame image data is classified by a finite state machine as a background, moving foreground, or temporally static object, namely as the temporally static object when the detected bounding box is distinguished from a background model of a scene image of the video data input and remains static in the scene image for a threshold period. The bounding box is tracked through matching masks in subsequent frame data of the video data input, and the object sub-classified within a visible sub-state, an occluded sub-state, or another sub-state that is not visible and not occluded as a function of a static value ratio. The ratio is a number of pixels determined to be static by tracking in a foreground region of the background model corresponding to the tracked object bounding box over a total number of pixels of the foreground region.02-28-2013

Jun Pan, Media, PA US

Patent application numberDescriptionPublished
20140200216BICYCLIC AROMATIC CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS - The present disclosure describes bicyclic aromatic carboxamide derivatives, as well as their compositions and methods of use. The compounds inhibit the activity of the Pim kinases, and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases.07-17-2014
20140200227THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS - The present disclosure describes thiazole and pyridine carboxamide derivatives, their compositions and methods of use. The compounds inhibit the activity of the Pim kinases and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases.07-17-2014
20150057265FURO- AND THIENO-PYRIDINE CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS - The present disclosure describes furo- and thieno-pyridine carboxamide compounds, as well as their compositions and methods of use. The compounds inhibit the activity of the Pim kinases, and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases.02-26-2015
20150329534THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS - The present disclosure describes thiazole and pyridine carboxamide derivatives, their compositions and methods of use. The compounds inhibit the activity of the Pim kinases and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases.11-19-2015

Ke Pan, Chadds Ford, PA US

Patent application numberDescriptionPublished
20160031819BASE ADDITION SALTS OF NITROXOLINE AND USES THEREOF - Novel base addition salts of nitroxoline with improved solubility and increased urine secretion under physiological conditions are described. Pharmaceutical compositions and methods of treatment using the pharmaceutical compositions are also described.02-04-2016

Kevin Pan, Phoenixville, PA US

Patent application numberDescriptionPublished
20090203751Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators - The present invention is directed to novel 1,2,4-thiadiazol-2-ium derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder.08-13-2009
201002800790NOVEL, 1,2,4-THIADIAZOLIUM DERIVATIVES AS MELANOCORTIN RECEPTOR MODULATORS - The present invention is directed to novel 1,2,4-thiadiazol-2-ium derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder.11-04-2010

Patent applications by Kevin Pan, Phoenixville, PA US

Rennan Pan, King Of Prussia, PA US

Patent application numberDescriptionPublished
20080255193Pharmaceutical Composition - A novel pharmaceutical composition comprising the NK10-16-2008
20080275082Pharmaceutical Composition - A novel pharmaceutical composition comprising the NK11-06-2008
20090285887Pharmaceutical Composition Comprising A Plurality of Mini-Tablets Comprising A Factor XA Inhibitor - A modified release pharmaceutical composition for oral administration comprising plural mini-tablets, comprising a therapeutically effective amount of a Factor Xa inhibitor within a matrix of polymer(s). The mini-tablets are suitably encapsulated within a gelatin capsule. A manufacturing process and method of use are also described.11-19-2009
20130171214Pharmaceutical Compositions - The present Invention relates to pharmaceutical compositions of (3S,11aR)-N-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide, useful in the treatment or prevention of Human Immunodeficiency Virus (HIV) infections.07-04-2013

Patent applications by Rennan Pan, King Of Prussia, PA US

Rennan Pan, Collegeville, PA US

Patent application numberDescriptionPublished
20120207800COMPOSITIONS - Novel compositions comprising omega-3 fatty acids and uses thereof are disclosed.08-16-2012

Wei-Hua Pan, Hummelstown, PA US

Patent application numberDescriptionPublished
20100036107RNA INTERFERENCE COMPOSITIONS AND METHODS - The invention provides isolated nucleic acids. For example, the invention provides isolated nucleic acids having at least one strand with both sense and antisense sequences that are complementary to each other. The invention also provides isolated nucleic acids having at least one strand that is a template for both sense and antisense sequences that are complementary to each other. In addition, the invention provides cells, viruses, and transgenic animals (e.g., transgenic non-human animals) containing one or more of the isolated nucleic acids provided herein as well as methods for using one or more of the isolated nucleic acids provided herein to reduce the level of an RNA (e.g., an mRNA) within a cell.02-11-2010

Patent applications by Wei-Hua Pan, Hummelstown, PA US

Wenxi Pan, Radnor, PA US

Patent application numberDescriptionPublished
20150031738CYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME - The present invention provides compounds, or pharmaceutically acceptable salts thereof, for inhibiting the growth of a microbe; treating a mammal having a microbial infection, mucositis, an ophthalmic infection, an otic infection, a cancer, or a 01-29-2015
20150094294COMPOUNDS AND METHODS FOR TREATING MALARIA - The present disclosure provides compounds, specifically pyrimidin-4,6-dicarboxylic acid amide derivatives, or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing said compounds. Also provided are methods for treating a mammal having malaria, or killing or inhibiting the growth of a 04-02-2015

Wenxi Pan, Glenmoore, PA US

Patent application numberDescriptionPublished
20110190344BENZIMIDAZOLE MODULATORS OF VR1 - The invention is directed to compounds of Formula (I):08-04-2011
20110190364BENZIMIDAZOLE MODULATORS OF VR1 - The invention is directed to compounds of Formula (I):08-04-2011
20140171438Hybrid Compounds And Methods Of Making And Using The Same - The present disclosure provides compounds, or pharmaceutically acceptable salts thereof, for inhibiting the growth of a microbe; treating a mammal having a microbial infection, malaria, mucositis, an ophthalmic infection, an otic infection, a cancer, or a 06-19-2014

Yongchun Pan, Newark, PA US

Patent application numberDescriptionPublished
20090291956SALTS OF 2-FLUORO-N-METHYL-4-[7-(QUINOLIN-6-YL-METHYL)-IMIDAZO[1,2-b][1,2,- 4]TRIAZIN-2-YL]BENZAMIDE AND PROCESSES RELATED TO PREPARING THE SAME - The present invention is directed to dihydrochloric acid and dibenzenesulfonic acid salts of the c-Met kinase inhibitor 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide, and pharmaceutical compositions thereof, useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways. The present invention further relates to processes and intermediates for preparing 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide, and salts thereof.11-26-2009
20140343030BIPYRAZOLE DERIVATIVES AS JAK INHIBITORS - The present invention provides compounds of Formula I:11-20-2014
20150133674PROCESS FOR THE SYNTHESIS OF AN INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR - The present application is directed to processes and intermediates for making 4-({2-[(aminosulfonyl)amino]ethyl}amino)-N-(3-bromo-4-fluorophenyl)-N′-hydroxy-1,2,5-oxadiazole-3-carboximidamide, which is an inhibitor of indoleamine 2,3-dioxygenase, useful in the treatment of cancer and other disorders.05-14-2015
20150148348SALTS OF 2-FLUORO-N-METHYL-4-[7-(QUINOLIN-6-YL-METHYL)- IMIDAZO[1,2-B][1,2,4]TRIAZIN-2-YL]BENZAMIDE AND PROCESSES RELATED TO PREPARING THE SAME - The present invention is directed to dihydrochloric acid and dibenzenesulfonic acid salts of the c-Met kinase inhibitor 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide, and pharmaceutical compositions thereof, useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways. The present invention further relates to processes and intermediates for preparing 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide, and salts thereof.05-28-2015

Patent applications by Yongchun Pan, Newark, PA US

Youlin Pan, Langhorne, PA US

Patent application numberDescriptionPublished
20100105817Silanes with Embedded Hydrophilicity, Dispersible Particles Derived Therefrom and Related Methods - The invention provides a silane compound that includes a hydrophobic group and a silane ester group linked by a hydrophilic group for use as a surface treatment to an inorganic material, such as a pigment, the silane including a hydrophobic group and a silane ester group linked by a hydrophilic group. The invention includes a coated particle including an inorganic material coated with the silane compound(s) and methods of improving the wettability and/or dispersibility of an inorganic material such as a pigment, wherein the method comprises depositing the silane compounds on the surface of a pigment.04-29-2010
20120071678TRIHYDRIDOSILYL-TERMINATED POLYSILANES AND METHODS OF PREPARATION - Novel trihydridosilyl-terminated polysilanes and methods for their synthesis, which are applicable to other polysilanes, are provided. The synthetic methods provide for facile preparation of products with minimal handling of pyrophoric intermediates and byproducts. The novel compounds contain at least three silicon-silicon bonds and at least one terminal silicon atom having three hydrogen substituents.03-22-2012
20120076840Alkoxysilane Derivatives of N-Acyl Amino Acids, N-Acyl Dipeptides, and N-Acyl Tripeptides, and Particles and Stable Oil-in-Water Formulations Using the Same - Hydrophilic N-acylamino acid, N-acyl dipeptide, and N-acyl tripeptide substituted silanes are prepared which can be utilized as reactive surface treatments for particles of pigments, minerals, and fillers. These treated particles form stable dispersions in the aqueous phase of oil-in-water mixtures that are suitable for cosmetic applications. The treated particles may also be used in pressed powder and color cosmetic formulations.03-29-2012
20120215019SILICONES DERIVED FROM 2-PROPENYL FUNCTIONAL CYCLIC TERPENES AND METHODS OF PREPARATION - Novel silicone compounds containing a siloxane moiety and at least one terpenyl moiety, such as limonenyl or valencenyl, and methods for their synthesis, are provided. The novel compounds are appropriate for incorporation into cosmetic formulations due to their low aroma, resistance to deterioration, and favorable solubility properties.08-23-2012
20120226002SILICON COMPOUNDS DERIVED FROM FURFURYL ALCOHOLS AND METHODS OF PREPARATION - Novel silicon compounds containing a siloxane or silane moiety and at least one moiety derived from a furfuryl alcohol, and methods for their synthesis, are provided. The novel compounds may be used as surface modifying agents, surfactants, defoamers, and as monomers for silicone polymerization.09-06-2012
20130274497LOW MOLECULAR WEIGHT CARBOSILANES, PRECURSORS THEREOF, AND METHODS OF PREPARATION - A series of silicon compounds are provided, which are excellent precursors to small carbosilanes, such as 1,3,5-trisilapentane, 2,4,6-trisilaheptane, tris(silylmethyl)silane and tetrakis(silylmethyl)silane. A method of preparing a carbosilane involves forming a Grignard, lithium, or metallic reagent from a halomethyltrialkoxysilane, reacting the Grignard, lithium, or metallic reagent with a dihalodihydridosilane, a trihalohydridosilane, a tetrahalosilane, a dialkoxydihydridosilane, a trialkoxyhydridosilane, or a tetraalkoxysilane to yield a carbosilane precursor, and reducing the precursor to form the carbosilane.10-17-2013
20140046017SILICON COMPOUNDS DERIVED FROM FURFURYL ALCOHOLS AND METHODS OF PREPARATION - Novel silicon compounds containing a siloxane or silane moiety and at least one moiety derived from a furfuryl alcohol, and methods for their synthesis, are provided. The novel compounds may be used as surface modifying agents, surfactants, defoamers, and as monomers for silicone polymerization.02-13-2014
20140275574PENDANT DIPODAL SILANES HAVING A DISILAPROPYL TERMINUS - Pendant dipodal silanes having formula (I) and methods for their synthesis are provided. In formula (I), R is an organic radical other than methyl and X may be a halogen, an alkoxy group, an acetoxy group, or a dialkylamino group. Films, adhesives, and composites formed from the inventive dipodal silanes generally demonstrate significantly greater hydrolytic resistance and film-forming ability than conventional silanes.09-18-2014
20150057462METHODS OF PREPARING LOW MOLECULAR WEIGHT CARBOSILANES AND PRECURSORS THEREOF - A series of silicon compounds are provided, which are excellent precursors to small carbosilanes, such as 1,3,5-trisilapentane, 2,4,6-trisilaheptane, tris(silylmethyl)silane and tetrakis(silylmethyl)silane. A method of preparing a carbosilane involves forming a Grignard, lithium, or metallic reagent from a halomethyltrialkoxysilane, reacting the Grignard, lithium, or metallic reagent with a dihalodihydridosilane, a trihalohydridosilane, a tetrahalosilane, a dialkoxydihydridosilane, a trialkoxyhydridosilane, or a tetraalkoxysilane to yield a carbosilane precursor, and reducing the precursor to form the carbosilane.02-26-2015

Patent applications by Youlin Pan, Langhorne, PA US

Zijiang Pan, Pittsburgh, PA US

Patent application numberDescriptionPublished
20120009114GAS PRESSURIZED SEPARATION COLUMN AND PROCESS TO GENERATE A HIGH PRESSURE PRODUCT GAS - The present invention provides a gas pressurized separation system to strip a product gas from a liquid stream and yield a high pressure gaseous effluent containing the product gas. The system comprises a gas pressurized stripping apparatus, such as a column, with at least one first inlet allowing flow of one or more liquid streams in a first direction and at least one second inlet allowing flow of one or more high pressure gas streams in a second direction, to strip the product gas into the high pressure gas stream and yield through at least one outlet a high pressure gaseous effluent containing the product gas; and two or more heat supplying apparatuses provided at different locations along the column. Processes for separating a product gas from a gaseous mixture to yield a high pressure gaseous effluent containing the product gas, utilize the gas pressurized separation system described above.01-12-2012
20140017622GAS PRESSURIZED SEPARATION COLUMN AND PROCESS TO GENERATE A HIGH PRESSURE PRODUCT GAS - The present invention provides a gas pressurized separation system to strip a product gas from a liquid stream and yield a high pressure gaseous effluent containing the product gas. The system comprises a gas pressurized stripping apparatus, such as a column, with at least one first inlet allowing flow of one or more liquid streams in a first direction and at least one second inlet allowing flow of one or more high pressure gas streams in a second direction, to strip the product gas into the high pressure gas stream and yield through at least one outlet a high pressure gaseous effluent containing the product gas; and two or more heat supplying apparatuses provided at different locations along the column. Processes for separating a product gas from a gaseous mixture to yield a high pressure gaseous effluent containing the product gas, utilize the gas pressurized separation system described above.01-16-2014
Website © 2016 Advameg, Inc.